Mindei
How it worksUse casesPilotEvidenceFAQs
Book a demo
Guide

Voice-biomarker screening for mental health, explained.

How voice-biomarker screening works, what the evidence shows, and how MindVoice turns a 45–90 second consent-led voice check-in into early, anonymised signals for distress, stress, burnout, fatigue and mental strain.

What voice-biomarker screening is

Voice-biomarker screening analyses how a person speaks — pitch, pace, pauses, energy, loudness and prosody — to surface early signals associated with psychological state. It does not transcribe or interpret the content of speech. A short spoken sample is enough: MindVoice uses a 45–90 second check-in.

The output is a signal, not a label. It indicates where attention or support may be worthwhile, and it is designed to be read alongside human judgement, existing wellbeing programmes and agreed referral pathways.

How MindVoice does it

  1. Consent-led check-in. A participant records a brief voice sample after clear consent, with privacy guardrails in place.
  2. Signal read. Acoustic features are mapped to validated models for the five current signals: distress, stress, burnout, fatigue and mental strain.
  3. Private support. The participant receives a private self-care plan by email and access to practical exercises such as box breathing, the physiological sigh and grounding.
  4. Anonymised cohort view. The organisation sees a strain map by team, site, function or year group — never individual health data — subject to minimum group-size thresholds.

What the evidence shows

MindVoice has completed a clinician-supervised, ethics-approved Phase 1 programme in India (CTRI/2025/09/094592), with 1,023 Phase 1 participants, a broader validation base of 1,665 participants and more than 40 hours of voice-led signal data. Development is guided by a Clinical Advisory Board, and Mindei Labs is a member of the NVIDIA Inception Program. Performance is reported at screening level and communicated per signal and deployment context.

Where it fits — and where it does not

Voice-biomarker screening works as an upstream layer: it can make emerging risk patterns visible earlier and route people toward EAP, counselling, occupational health or clinical review. It is not a diagnostic device, an emergency service, an employee-surveillance product or a performance-management tool, and it is not used for hiring, firing, promotion, compensation or discipline.

Common questions

What is a voice biomarker?
A voice biomarker is a measurable feature of how someone speaks — pitch, pace, pauses, loudness, energy, prosody and micro-timing — that correlates with a physiological or psychological state. Voice-biomarker screening reads these acoustic patterns, not the words or meaning of what is said.
Are voice biomarkers a diagnosis?
No. Voice-biomarker screening is a screening and signalling layer. It can indicate that a person or a cohort may benefit from support or further assessment; it does not diagnose a medical condition and is not an emergency service.
How accurate is voice-biomarker screening?
Accuracy depends on the signal, the population and how the screen is deployed. MindVoice reports screening-level performance and communicates it per signal and context. Its models are backed by a clinician-supervised, ethics-approved Phase 1 programme (CTRI/2025/09/094592) and a broader validation base of 1,665 participants.
Does language or accent affect voice-biomarker screening?
It can. Speaking style, language, accent and recording conditions all matter. MindVoice is built and validated for real-world diversity, and cohort-level reporting with minimum group-size thresholds reduces the impact of individual variation.
Is voice-biomarker screening private?
With MindVoice, the browser demo processes audio locally and never uploads it. In a pilot, capture is consent-led, individual results are private to the participant, and the organisation only ever sees anonymised cohort signals.
See it on your own cohort.

A 6–10 week MindVoice pilot turns voice-biomarker screening into a board-ready readout — participation, a private self-care plan for every participant, and an anonymised cohort signal map.

Book a demo

Related: Workforce mental-health screening without another survey · All MindVoice FAQs · Try the live voice demo

Mindei

Human Signals. Health Intelligence.

ExploreHow it worksLive demoUse casesPilotAbout Mindei
GuidesWorkforce mental-health screeningVoice-biomarker screeningAll FAQs
TrustEvidencePrivacy policyFAQsTerms of useData request
ContactBook a demosupport@mindei.in

+91 93608 12023

Disclaimer: Mindei is not designed to assist with crises such as abuse, severe mental health conditions that may cause feelings of suicide, harm to self, or any other medical emergencies. It can only suggest that users seek advanced and professional medical help. Please get in touch with TeleManas (14416 or 1 800 891 4416) in case of an emergency. You must be at least 18 years of age to use Mindei. If you are between 14 and 18 years of age, please read through the Terms of Service and Privacy Policy along with your parents or legal guardian to understand eligibility before use. Mindei is not designed to be used by children under 14.

© 2026 Mindei Labs Private LimitedCIN: U95000KA2022FTC157427MindVoice is non-diagnostic and is not an emergency service.

If you or someone you know may be in immediate danger, contact local emergency services. In India, Tele-MANAS is available at 14416 or 1-800-891-4416.